GLP-1 Semaglutide is a synthetic research peptide designed as a GLP-1 receptor agonist, targeting pathways involved in glucose regulation and metabolic signaling.

In preclinical studies and metabolic research models, it has been associated with reductions in body weight along with improvements in insulin sensitivity, glucose regulation, and appetite-related signaling pathways.

This product is supplied strictly for research purposes only and is not intended for human or animal consumption or therapeutic use.